Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.41184546 |
2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.34423785 |
3 | regulation of gamma-delta T cell activation (GO:0046643) | 5.59737414 |
4 | positive thymic T cell selection (GO:0045059) | 5.12652895 |
5 | negative T cell selection (GO:0043383) | 5.03102404 |
6 | positive T cell selection (GO:0043368) | 5.00086603 |
7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.73918304 |
8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.73918304 |
9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.59381286 |
10 | T cell selection (GO:0045058) | 4.51943990 |
11 | negative thymic T cell selection (GO:0045060) | 4.50082448 |
12 | positive regulation of histone deacetylation (GO:0031065) | 4.43425967 |
13 | thymic T cell selection (GO:0045061) | 4.34302831 |
14 | V(D)J recombination (GO:0033151) | 4.29110657 |
15 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.24711913 |
16 | response to interleukin-15 (GO:0070672) | 4.13565988 |
17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.00600330 |
18 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.99859361 |
19 | interferon-gamma production (GO:0032609) | 3.98805682 |
20 | Peyers patch development (GO:0048541) | 3.77262605 |
21 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.77262605 |
22 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.70956823 |
23 | mannose metabolic process (GO:0006013) | 3.69806876 |
24 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.69740887 |
25 | endothelial tube morphogenesis (GO:0061154) | 3.69276894 |
26 | morphogenesis of an endothelium (GO:0003159) | 3.69276894 |
27 | T cell receptor signaling pathway (GO:0050852) | 3.67372391 |
28 | positive regulation of protein deacetylation (GO:0090312) | 3.64261611 |
29 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.59237497 |
30 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.57538394 |
31 | negative regulation of cell killing (GO:0031342) | 3.57498523 |
32 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.57498523 |
33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.55213224 |
34 | natural killer cell differentiation (GO:0001779) | 3.53337841 |
35 | T cell homeostasis (GO:0043029) | 3.46031876 |
36 | T cell costimulation (GO:0031295) | 3.39016553 |
37 | positive regulation of interleukin-2 production (GO:0032743) | 3.36993406 |
38 | regulation of regulatory T cell differentiation (GO:0045589) | 3.35956404 |
39 | lymphocyte costimulation (GO:0031294) | 3.31719755 |
40 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.29063761 |
41 | modulation by symbiont of host immune response (GO:0052553) | 3.29063761 |
42 | positive regulation by symbiont of host defense response (GO:0052509) | 3.29063761 |
43 | modulation by symbiont of host defense response (GO:0052031) | 3.29063761 |
44 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.29063761 |
45 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.29063761 |
46 | cellular hyperosmotic response (GO:0071474) | 3.27080887 |
47 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.24381699 |
48 | germinal center formation (GO:0002467) | 3.20653432 |
49 | negative regulation of phagocytosis (GO:0050765) | 3.12534140 |
50 | response to laminar fluid shear stress (GO:0034616) | 3.11386972 |
51 | response to muramyl dipeptide (GO:0032495) | 3.10947781 |
52 | viral transcription (GO:0019083) | 3.10689032 |
53 | DNA unwinding involved in DNA replication (GO:0006268) | 3.06619709 |
54 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.04791880 |
55 | positive regulation of gene expression, epigenetic (GO:0045815) | 3.03851111 |
56 | cellular response to interleukin-15 (GO:0071350) | 3.02710397 |
57 | tolerance induction (GO:0002507) | 3.00160662 |
58 | regulation of T cell tolerance induction (GO:0002664) | 3.00099725 |
59 | activated T cell proliferation (GO:0050798) | 2.97823944 |
60 | regulation of thymocyte apoptotic process (GO:0070243) | 2.97104608 |
61 | T cell differentiation (GO:0030217) | 2.94543420 |
62 | positive regulation of granulocyte differentiation (GO:0030854) | 2.93425618 |
63 | positive regulation of tolerance induction (GO:0002645) | 2.93084058 |
64 | detection of bacterium (GO:0016045) | 2.90269347 |
65 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.89976686 |
66 | positive regulation of B cell differentiation (GO:0045579) | 2.89974395 |
67 | detection of other organism (GO:0098543) | 2.89937102 |
68 | translational termination (GO:0006415) | 2.89734603 |
69 | stress fiber assembly (GO:0043149) | 2.88918324 |
70 | positive regulation of isotype switching (GO:0045830) | 2.88516521 |
71 | B cell receptor signaling pathway (GO:0050853) | 2.88126168 |
72 | ribosomal small subunit assembly (GO:0000028) | 2.87848837 |
73 | regulation of histone H3-K27 methylation (GO:0061085) | 2.83292110 |
74 | leukocyte aggregation (GO:0070486) | 2.81357450 |
75 | apoptotic process involved in morphogenesis (GO:0060561) | 2.80880631 |
76 | cellular extravasation (GO:0045123) | 2.78666102 |
77 | cellular response to interleukin-4 (GO:0071353) | 2.77666933 |
78 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.76260265 |
79 | regulation of extracellular matrix disassembly (GO:0010715) | 2.74104422 |
80 | establishment of endothelial barrier (GO:0061028) | 2.72712592 |
81 | megakaryocyte development (GO:0035855) | 2.72384991 |
82 | lymphocyte homeostasis (GO:0002260) | 2.72144637 |
83 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.71237370 |
84 | atrioventricular valve morphogenesis (GO:0003181) | 2.71047248 |
85 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.70748685 |
86 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.69698011 |
87 | negative regulation of RNA splicing (GO:0033119) | 2.69633452 |
88 | regulation of B cell differentiation (GO:0045577) | 2.69581862 |
89 | cell-substrate adherens junction assembly (GO:0007045) | 2.69479958 |
90 | focal adhesion assembly (GO:0048041) | 2.69479958 |
91 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.68214657 |
92 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.67838718 |
93 | protein localization to kinetochore (GO:0034501) | 2.67155006 |
94 | lymph node development (GO:0048535) | 2.67068698 |
95 | regulation of ARF GTPase activity (GO:0032312) | 2.65198808 |
96 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.64975624 |
97 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.64826264 |
98 | adherens junction assembly (GO:0034333) | 2.63498809 |
99 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.63068359 |
100 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.62117615 |
101 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.61860616 |
102 | regulation of necroptotic process (GO:0060544) | 2.61052797 |
103 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.60973099 |
104 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.60852890 |
105 | cell-substrate junction assembly (GO:0007044) | 2.59652143 |
106 | translational elongation (GO:0006414) | 2.57777392 |
107 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.56618571 |
108 | T cell migration (GO:0072678) | 2.56497637 |
109 | ribosomal small subunit biogenesis (GO:0042274) | 2.55901159 |
110 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.55831762 |
111 | response to peptidoglycan (GO:0032494) | 2.55596162 |
112 | embryonic hemopoiesis (GO:0035162) | 2.55352317 |
113 | definitive hemopoiesis (GO:0060216) | 2.54864032 |
114 | barbed-end actin filament capping (GO:0051016) | 2.54823215 |
115 | regulation of histone H3-K4 methylation (GO:0051569) | 2.53822084 |
116 | positive regulation of receptor recycling (GO:0001921) | 2.53538445 |
117 | modulation by symbiont of host cellular process (GO:0044068) | 2.53416683 |
118 | macrophage activation involved in immune response (GO:0002281) | 2.53296672 |
119 | nucleosome disassembly (GO:0006337) | 2.52845626 |
120 | protein-DNA complex disassembly (GO:0032986) | 2.52845626 |
121 | mRNA stabilization (GO:0048255) | 2.52720405 |
122 | RNA stabilization (GO:0043489) | 2.52720405 |
123 | signal complex assembly (GO:0007172) | 2.52142491 |
124 | natural killer cell activation (GO:0030101) | 2.51446366 |
125 | embryonic process involved in female pregnancy (GO:0060136) | 2.51314138 |
126 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.51048978 |
127 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.51046651 |
128 | response to interleukin-4 (GO:0070670) | 2.49567343 |
129 | * positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.47282004 |
130 | negative regulation of type 2 immune response (GO:0002829) | 2.47262338 |
131 | * regulation of interleukin-2 production (GO:0032663) | 2.47238444 |
132 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.46500135 |
133 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.46500135 |
134 | NIK/NF-kappaB signaling (GO:0038061) | 2.46015565 |
135 | detection of external biotic stimulus (GO:0098581) | 2.45787911 |
136 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.45609056 |
137 | negative regulation of granulocyte differentiation (GO:0030853) | 2.45179067 |
138 | positive regulation by host of viral transcription (GO:0043923) | 2.44934747 |
139 | alpha-beta T cell activation (GO:0046631) | 2.44582901 |
140 | T cell activation (GO:0042110) | 2.43997365 |
141 | T cell differentiation in thymus (GO:0033077) | 2.43895992 |
142 | activation of JUN kinase activity (GO:0007257) | 2.43404464 |
143 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.43260436 |
144 | protein localization to endosome (GO:0036010) | 2.43239494 |
145 | modulation by virus of host process (GO:0019054) | 2.42854235 |
146 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.42774433 |
147 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.42774433 |
148 | pinocytosis (GO:0006907) | 2.42448060 |
149 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.38651614 |
150 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.36556786 |
151 | negative regulation of cell size (GO:0045792) | 2.34705595 |
152 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.34049902 |
153 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.32814174 |
154 | positive regulation of Rap GTPase activity (GO:0032854) | 2.32447882 |
155 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.32189429 |
156 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.31462116 |
157 | response to fluid shear stress (GO:0034405) | 2.31012845 |
158 | semaphorin-plexin signaling pathway (GO:0071526) | 2.29382728 |
159 | venous blood vessel morphogenesis (GO:0048845) | 2.28968493 |
160 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.28840500 |
161 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.28840500 |
162 | negative regulation of necroptotic process (GO:0060546) | 2.28616810 |
163 | response to host (GO:0075136) | 2.28549680 |
164 | response to host defenses (GO:0052200) | 2.28549680 |
165 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.28549680 |
166 | cellular response to virus (GO:0098586) | 2.28343958 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.42575761 |
2 | * MYC_22102868_ChIP-Seq_BL_Human | 4.55425487 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.97678189 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.88884041 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.73376806 |
6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.25295260 |
7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.12075329 |
8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.86530772 |
9 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.71307910 |
10 | MAF_26560356_Chip-Seq_TH1_Human | 2.61341417 |
11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.58620521 |
12 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.54021511 |
13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.43011444 |
14 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.41185335 |
15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.40941769 |
16 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.40500112 |
17 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.35820109 |
18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.35120154 |
19 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.34738819 |
20 | * MYB_26560356_Chip-Seq_TH2_Human | 2.34481293 |
21 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.32415269 |
22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.30013379 |
23 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.25399219 |
24 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.17521491 |
25 | MYB_26560356_Chip-Seq_TH1_Human | 2.13648129 |
26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.99343391 |
27 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.98742038 |
28 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.86486915 |
29 | MAF_26560356_Chip-Seq_TH2_Human | 1.81643130 |
30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77777276 |
31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.76021505 |
32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.74998331 |
33 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74302867 |
34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.73184740 |
35 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.68273858 |
36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67283978 |
37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.67278134 |
38 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.65218387 |
39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.64845013 |
40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59983502 |
41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55872203 |
42 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.54773728 |
43 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.54529274 |
44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.53820792 |
45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.51046436 |
46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.47498863 |
47 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.46899756 |
48 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.42627214 |
49 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.41124504 |
50 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40889807 |
51 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.40625986 |
52 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.40393356 |
53 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.37961286 |
54 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.37920466 |
55 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.35659024 |
56 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.35407812 |
57 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.34922676 |
58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.33295249 |
59 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32076055 |
60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.30237305 |
61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.29865508 |
62 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29154217 |
63 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26193402 |
64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25349341 |
65 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23222274 |
66 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.21271246 |
67 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.18077070 |
68 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.17699320 |
69 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.17210103 |
70 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15515273 |
71 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.15432628 |
72 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14833897 |
73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13882608 |
74 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13584695 |
75 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.13481984 |
76 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12697769 |
77 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.10246471 |
78 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10153379 |
79 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.08956110 |
80 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.08676695 |
81 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.07703668 |
82 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.07648436 |
83 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07513488 |
84 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07167002 |
85 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.06828994 |
86 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06280604 |
87 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.05906941 |
88 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05391013 |
89 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04373118 |
90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04372603 |
91 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.04212412 |
92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03861883 |
93 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.03842937 |
94 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03651406 |
95 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02837818 |
96 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01080504 |
97 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01080177 |
98 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00901627 |
99 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.99779999 |
100 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99246062 |
101 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98980161 |
102 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98886942 |
103 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98424630 |
104 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98283788 |
105 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97555133 |
106 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.97200510 |
107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96900369 |
108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96563560 |
109 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.95884508 |
110 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.95721706 |
111 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.94887030 |
112 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.94620220 |
113 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.94554763 |
114 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94539114 |
115 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93208440 |
116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93076222 |
117 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.91317585 |
118 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91081459 |
119 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.90311336 |
120 | * P68_20966046_ChIP-Seq_HELA_Human | 0.89758392 |
121 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.89748282 |
122 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.88896574 |
123 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.87653816 |
124 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87621785 |
125 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.87021049 |
126 | KDM2B_26808549_Chip-Seq_K562_Human | 0.86848633 |
127 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.86090848 |
128 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.86062144 |
129 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85257385 |
130 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.84870365 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003763_abnormal_thymus_physiology | 3.76499905 |
2 | MP0002396_abnormal_hematopoietic_system | 3.53062583 |
3 | MP0000685_abnormal_immune_system | 2.91755026 |
4 | MP0004808_abnormal_hematopoietic_stem | 2.66222102 |
5 | MP0003300_gastrointestinal_ulcer | 2.63723929 |
6 | MP0000703_abnormal_thymus_morphology | 2.57520311 |
7 | MP0002166_altered_tumor_susceptibility | 2.53483575 |
8 | MP0005671_abnormal_response_to | 2.40155462 |
9 | MP0010352_gastrointestinal_tract_polyps | 2.33665929 |
10 | MP0002398_abnormal_bone_marrow | 2.31335283 |
11 | MP0009278_abnormal_bone_marrow | 2.29309716 |
12 | MP0010368_abnormal_lymphatic_system | 2.23875696 |
13 | MP0001800_abnormal_humoral_immune | 2.22580578 |
14 | MP0005387_immune_system_phenotype | 2.15200386 |
15 | MP0001790_abnormal_immune_system | 2.15200386 |
16 | MP0001879_abnormal_lymphatic_vessel | 2.02989574 |
17 | MP0003303_peritoneal_inflammation | 2.01250525 |
18 | MP0003705_abnormal_hypodermis_morpholog | 1.99949166 |
19 | MP0002722_abnormal_immune_system | 1.98654871 |
20 | MP0009333_abnormal_splenocyte_physiolog | 1.97127032 |
21 | MP0006054_spinal_hemorrhage | 1.89744608 |
22 | MP0001545_abnormal_hematopoietic_system | 1.85658304 |
23 | MP0005397_hematopoietic_system_phenotyp | 1.85658304 |
24 | MP0008260_abnormal_autophagy | 1.83632986 |
25 | MP0000689_abnormal_spleen_morphology | 1.83267894 |
26 | MP0002405_respiratory_system_inflammati | 1.82088132 |
27 | MP0003279_aneurysm | 1.81745529 |
28 | MP0000716_abnormal_immune_system | 1.81545964 |
29 | MP0010155_abnormal_intestine_physiology | 1.81270160 |
30 | MP0002006_tumorigenesis | 1.79164131 |
31 | MP0002420_abnormal_adaptive_immunity | 1.79081308 |
32 | MP0001819_abnormal_immune_cell | 1.74645691 |
33 | MP0005451_abnormal_body_composition | 1.72249744 |
34 | MP0005275_abnormal_skin_tensile | 1.71242382 |
35 | MP0002132_abnormal_respiratory_system | 1.67743601 |
36 | MP0001835_abnormal_antigen_presentation | 1.67342058 |
37 | MP0002723_abnormal_immune_serum | 1.67003827 |
38 | MP0002933_joint_inflammation | 1.66381293 |
39 | MP0002419_abnormal_innate_immunity | 1.65365536 |
40 | MP0002452_abnormal_antigen_presenting | 1.64838216 |
41 | MP0008961_abnormal_basal_metabolism | 1.62462105 |
42 | MP0002429_abnormal_blood_cell | 1.61866796 |
43 | MP0005000_abnormal_immune_tolerance | 1.58048083 |
44 | MP0004947_skin_inflammation | 1.57953973 |
45 | MP0001533_abnormal_skeleton_physiology | 1.55397651 |
46 | MP0005503_abnormal_tendon_morphology | 1.53959106 |
47 | MP0003191_abnormal_cellular_cholesterol | 1.52857089 |
48 | MP0000465_gastrointestinal_hemorrhage | 1.52584040 |
49 | MP0003436_decreased_susceptibility_to | 1.51697492 |
50 | MP0003172_abnormal_lysosome_physiology | 1.48547899 |
51 | MP0001873_stomach_inflammation | 1.48272742 |
52 | MP0005058_abnormal_lysosome_morphology | 1.44849685 |
53 | MP0003866_abnormal_defecation | 1.42392630 |
54 | MP0003566_abnormal_cell_adhesion | 1.39441804 |
55 | MP0002877_abnormal_melanocyte_morpholog | 1.36620097 |
56 | MP0000490_abnormal_crypts_of | 1.35931438 |
57 | MP0004858_abnormal_nervous_system | 1.33154327 |
58 | MP0009785_altered_susceptibility_to | 1.32397087 |
59 | MP0005076_abnormal_cell_differentiation | 1.30357206 |
60 | MP0001849_ear_inflammation | 1.29298417 |
61 | MP0005023_abnormal_wound_healing | 1.27459789 |
62 | MP0003453_abnormal_keratinocyte_physiol | 1.26553423 |
63 | MP0005083_abnormal_biliary_tract | 1.24626527 |
64 | MP0005025_abnormal_response_to | 1.23651787 |
65 | MP0004185_abnormal_adipocyte_glucose | 1.23117806 |
66 | MP0000678_abnormal_parathyroid_gland | 1.20585919 |
67 | MP0005375_adipose_tissue_phenotype | 1.17467968 |
68 | MP0003724_increased_susceptibility_to | 1.15907267 |
69 | MP0004381_abnormal_hair_follicle | 1.15658687 |
70 | MP0005666_abnormal_adipose_tissue | 1.15286443 |
71 | MP0003828_pulmonary_edema | 1.15234419 |
72 | MP0005390_skeleton_phenotype | 1.15209442 |
73 | MP0000733_abnormal_muscle_development | 1.13683424 |
74 | MP0002019_abnormal_tumor_incidence | 1.12860619 |
75 | MP0003077_abnormal_cell_cycle | 1.12490717 |
76 | MP0001348_abnormal_lacrimal_gland | 1.09909965 |
77 | MP0003091_abnormal_cell_migration | 1.09824650 |
78 | MP0010094_abnormal_chromosome_stability | 1.08345805 |
79 | MP0000003_abnormal_adipose_tissue | 1.07594662 |
80 | MP0001958_emphysema | 1.07572201 |
81 | MP0002060_abnormal_skin_morphology | 1.06696967 |
82 | * MP0002925_abnormal_cardiovascular_devel | 1.06603711 |
83 | MP0008438_abnormal_cutaneous_collagen | 1.06376103 |
84 | MP0001851_eye_inflammation | 1.03851190 |
85 | MP0002254_reproductive_system_inflammat | 1.02674495 |
86 | MP0009384_cardiac_valve_regurgitation | 1.02517631 |
87 | MP0003984_embryonic_growth_retardation | 1.02127360 |
88 | MP0000858_altered_metastatic_potential | 1.01850301 |
89 | MP0010630_abnormal_cardiac_muscle | 1.01569580 |
90 | MP0005464_abnormal_platelet_physiology | 1.01467076 |
91 | MP0000751_myopathy | 1.01294396 |
92 | MP0002088_abnormal_embryonic_growth/wei | 1.00801748 |
93 | MP0002796_impaired_skin_barrier | 1.00673469 |
94 | MP0000350_abnormal_cell_proliferation | 0.99666585 |
95 | MP0004957_abnormal_blastocyst_morpholog | 0.96919206 |
96 | MP0003111_abnormal_nucleus_morphology | 0.96751200 |
97 | MP0001730_embryonic_growth_arrest | 0.96108651 |
98 | MP0001243_abnormal_dermal_layer | 0.95613291 |
99 | MP0002086_abnormal_extraembryonic_tissu | 0.92377411 |
100 | MP0004084_abnormal_cardiac_muscle | 0.91705993 |
101 | MP0006082_CNS_inflammation | 0.91049528 |
102 | MP0001542_abnormal_bone_strength | 0.89706153 |
103 | MP0001845_abnormal_inflammatory_respons | 0.89455878 |
104 | MP0003448_altered_tumor_morphology | 0.88973068 |
105 | MP0006138_congestive_heart_failure | 0.88454595 |
106 | MP0001672_abnormal_embryogenesis/_devel | 0.88043823 |
107 | MP0005380_embryogenesis_phenotype | 0.88043823 |
108 | MP0008770_decreased_survivor_rate | 0.85246232 |
109 | MP0004510_myositis | 0.85124668 |
110 | MP0009840_abnormal_foam_cell | 0.84230133 |
111 | MP0004197_abnormal_fetal_growth/weight/ | 0.82911833 |
112 | MP0005621_abnormal_cell_physiology | 0.81246975 |
113 | MP0008007_abnormal_cellular_replicative | 0.81108499 |
114 | MP0001853_heart_inflammation | 0.80817778 |
115 | MP0003795_abnormal_bone_structure | 0.80711469 |
116 | MP0005164_abnormal_response_to | 0.79550042 |
117 | * MP0002128_abnormal_blood_circulation | 0.79478556 |
118 | MP0002148_abnormal_hypersensitivity_rea | 0.78928777 |
119 | MP0008057_abnormal_DNA_replication | 0.78685409 |
120 | * MP0000266_abnormal_heart_morphology | 0.77153652 |
121 | MP0004272_abnormal_basement_membrane | 0.75378522 |
122 | MP0001915_intracranial_hemorrhage | 0.74027016 |
123 | * MP0001784_abnormal_fluid_regulation | 0.72941515 |
124 | * MP0002080_prenatal_lethality | 0.72328491 |
125 | MP0002998_abnormal_bone_remodeling | 0.71303420 |
126 | MP0000750_abnormal_muscle_regeneration | 0.71237053 |
127 | MP0000477_abnormal_intestine_morphology | 0.70165460 |
128 | MP0000313_abnormal_cell_death | 0.70095316 |
129 | * MP0001614_abnormal_blood_vessel | 0.69899112 |
130 | * MP0000767_abnormal_smooth_muscle | 0.69687839 |
131 | MP0004087_abnormal_muscle_fiber | 0.67051649 |
132 | MP0000249_abnormal_blood_vessel | 0.66157621 |
133 | MP0009931_abnormal_skin_appearance | 0.65894977 |
134 | MP0005409_darkened_coat_color | 0.65670520 |
Rank | Gene Set | Z-score |
---|---|---|
1 | T lymphocytopenia (HP:0005403) | 5.59187002 |
2 | Panhypogammaglobulinemia (HP:0003139) | 5.31432371 |
3 | Abnormality of T cell number (HP:0011839) | 5.23548671 |
4 | B lymphocytopenia (HP:0010976) | 4.37370444 |
5 | Abnormality of B cell number (HP:0010975) | 4.37370444 |
6 | Recurrent viral infections (HP:0004429) | 4.24128865 |
7 | Severe combined immunodeficiency (HP:0004430) | 4.06855368 |
8 | Combined immunodeficiency (HP:0005387) | 4.03798141 |
9 | Eczematoid dermatitis (HP:0000976) | 3.68656934 |
10 | Abnormality of T cells (HP:0002843) | 3.64864356 |
11 | Thyroiditis (HP:0100646) | 3.45226061 |
12 | Abnormality of the fingertips (HP:0001211) | 3.35044391 |
13 | Abnormality of the nasal mucosa (HP:0000433) | 3.29013138 |
14 | Recurrent fungal infections (HP:0002841) | 3.23459222 |
15 | Papilloma (HP:0012740) | 3.14755825 |
16 | Verrucae (HP:0200043) | 3.14755825 |
17 | Obstructive sleep apnea (HP:0002870) | 3.12295126 |
18 | Hypoplasia of the thymus (HP:0000778) | 3.09835252 |
19 | Protrusio acetabuli (HP:0003179) | 3.09418525 |
20 | Recurrent bronchitis (HP:0002837) | 3.05329149 |
21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.05079871 |
22 | Cellulitis (HP:0100658) | 3.04547413 |
23 | Eosinophilia (HP:0001880) | 3.00625780 |
24 | Agammaglobulinemia (HP:0004432) | 3.00557456 |
25 | Increased density of long bones (HP:0006392) | 2.94219390 |
26 | Chronic otitis media (HP:0000389) | 2.93918013 |
27 | Nasal polyposis (HP:0100582) | 2.90790147 |
28 | Cervical subluxation (HP:0003308) | 2.87386416 |
29 | Broad face (HP:0000283) | 2.86627285 |
30 | Spontaneous hematomas (HP:0007420) | 2.84052390 |
31 | Hyperacusis (HP:0010780) | 2.74936751 |
32 | Cerebral aneurysm (HP:0004944) | 2.71614790 |
33 | Increased variability in muscle fiber diameter (HP:0003557) | 2.64472351 |
34 | Aortic aneurysm (HP:0004942) | 2.55838663 |
35 | Granulocytopenia (HP:0001913) | 2.52939905 |
36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.51620379 |
37 | Vascular tortuosity (HP:0004948) | 2.48409291 |
38 | Hypoproteinemia (HP:0003075) | 2.46301106 |
39 | Fragile skin (HP:0001030) | 2.40837122 |
40 | Ulnar bowing (HP:0003031) | 2.40386226 |
41 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.37609522 |
42 | IgM deficiency (HP:0002850) | 2.37096517 |
43 | Abnormality of eosinophils (HP:0001879) | 2.37062404 |
44 | Arterial tortuosity (HP:0005116) | 2.36538119 |
45 | Distal lower limb amyotrophy (HP:0008944) | 2.35622191 |
46 | Mitral regurgitation (HP:0001653) | 2.34377246 |
47 | Bicuspid aortic valve (HP:0001647) | 2.32782162 |
48 | Gastrointestinal inflammation (HP:0004386) | 2.31966344 |
49 | Leukocytosis (HP:0001974) | 2.31030574 |
50 | Biconcave vertebral bodies (HP:0004586) | 2.25115090 |
51 | Blue sclerae (HP:0000592) | 2.24936274 |
52 | Meningitis (HP:0001287) | 2.24841928 |
53 | Broad metatarsal (HP:0001783) | 2.22194998 |
54 | Recurrent abscess formation (HP:0002722) | 2.21854956 |
55 | Spondylolisthesis (HP:0003302) | 2.21581229 |
56 | Increased connective tissue (HP:0009025) | 2.21318854 |
57 | IgG deficiency (HP:0004315) | 2.21254184 |
58 | Spinal rigidity (HP:0003306) | 2.20369392 |
59 | Long eyelashes (HP:0000527) | 2.18093508 |
60 | Inflammation of the large intestine (HP:0002037) | 2.18074747 |
61 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.15231138 |
62 | Recurrent cutaneous fungal infections (HP:0011370) | 2.15231138 |
63 | Atrophic scars (HP:0001075) | 2.14713406 |
64 | Basal cell carcinoma (HP:0002671) | 2.14651548 |
65 | Broad palm (HP:0001169) | 2.13778461 |
66 | Abnormality of macrophages (HP:0004311) | 2.13760207 |
67 | Mitral valve prolapse (HP:0001634) | 2.09263479 |
68 | Spinal cord lesions (HP:0100561) | 2.09017237 |
69 | Syringomyelia (HP:0003396) | 2.09017237 |
70 | Genu recurvatum (HP:0002816) | 2.08735299 |
71 | Vertebral compression fractures (HP:0002953) | 2.07553388 |
72 | Gingivitis (HP:0000230) | 2.06943693 |
73 | Short 4th metacarpal (HP:0010044) | 2.06540132 |
74 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.06540132 |
75 | Thrombocytosis (HP:0001894) | 2.05497719 |
76 | Metaphyseal cupping (HP:0003021) | 2.05209833 |
77 | Abnormality of T cell physiology (HP:0011840) | 2.04360258 |
78 | Recurrent bacterial skin infections (HP:0005406) | 2.04327906 |
79 | Prolonged bleeding time (HP:0003010) | 2.03872923 |
80 | Joint laxity (HP:0001388) | 2.02846777 |
81 | Macroorchidism (HP:0000053) | 2.01895351 |
82 | Dilatation of the ascending aorta (HP:0005111) | 2.00595918 |
83 | Chest pain (HP:0100749) | 1.99914614 |
84 | Emphysema (HP:0002097) | 1.98350269 |
85 | Wormian bones (HP:0002645) | 1.97774802 |
86 | Nonimmune hydrops fetalis (HP:0001790) | 1.97452575 |
87 | Polycythemia (HP:0001901) | 1.97337098 |
88 | Aortic regurgitation (HP:0001659) | 1.97279296 |
89 | Aortic dissection (HP:0002647) | 1.95268326 |
90 | Ankle contracture (HP:0006466) | 1.94867945 |
91 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.94736803 |
92 | Gastrointestinal infarctions (HP:0005244) | 1.94703577 |
93 | Interstitial pulmonary disease (HP:0006530) | 1.94208795 |
94 | Pustule (HP:0200039) | 1.94085119 |
95 | Persistence of primary teeth (HP:0006335) | 1.93462106 |
96 | Joint stiffness (HP:0001387) | 1.93419990 |
97 | Abnormal number of erythroid precursors (HP:0012131) | 1.91840635 |
98 | Polygenic inheritance (HP:0010982) | 1.91109598 |
99 | Obstructive lung disease (HP:0006536) | 1.89248586 |
100 | Chronic obstructive pulmonary disease (HP:0006510) | 1.89248586 |
101 | High pitched voice (HP:0001620) | 1.88153592 |
102 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.86826804 |
103 | Orchitis (HP:0100796) | 1.86820475 |
104 | Distal lower limb muscle weakness (HP:0009053) | 1.85577135 |
105 | Thin bony cortex (HP:0002753) | 1.85300335 |
106 | Cutis marmorata (HP:0000965) | 1.85165848 |
107 | Shallow orbits (HP:0000586) | 1.84135436 |
108 | Disproportionate tall stature (HP:0001519) | 1.83962098 |
109 | Autoimmune thrombocytopenia (HP:0001973) | 1.83828570 |
110 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.83448951 |
111 | Abnormality of the peritoneum (HP:0002585) | 1.81293413 |
112 | Lymphopenia (HP:0001888) | 1.81051736 |
113 | Hemorrhage of the eye (HP:0011885) | 1.80854854 |
114 | Chronic sinusitis (HP:0011109) | 1.80805054 |
115 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.80507084 |
116 | Long palpebral fissure (HP:0000637) | 1.80432484 |
117 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.80044166 |
118 | Easy fatigability (HP:0003388) | 1.79701965 |
119 | Abnormality of oral frenula (HP:0000190) | 1.79444503 |
120 | Hematochezia (HP:0002573) | 1.78185291 |
121 | Bowel diverticulosis (HP:0005222) | 1.77998754 |
122 | Epistaxis (HP:0000421) | 1.75942386 |
123 | Colitis (HP:0002583) | 1.74829895 |
124 | Ankyloglossia (HP:0010296) | 1.74382023 |
125 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.74366825 |
126 | Lymphoma (HP:0002665) | 1.72663590 |
127 | Dislocated radial head (HP:0003083) | 1.72328226 |
128 | Aneurysm (HP:0002617) | 1.72286540 |
129 | Lymphangioma (HP:0100764) | 1.72160055 |
130 | Abnormal platelet volume (HP:0011876) | 1.71637495 |
131 | Peritonitis (HP:0002586) | 1.71128480 |
132 | Premature skin wrinkling (HP:0100678) | 1.71094137 |
133 | Vertebral arch anomaly (HP:0008438) | 1.69831421 |
134 | Ectopia lentis (HP:0001083) | 1.69550248 |
135 | Skin tags (HP:0010609) | 1.69441243 |
136 | Myositis (HP:0100614) | 1.69357075 |
137 | Type 1 muscle fiber predominance (HP:0003803) | 1.68900751 |
138 | Increased nuchal translucency (HP:0010880) | 1.68743643 |
139 | Abnormal vertebral ossification (HP:0100569) | 1.68205102 |
140 | Bowing of the arm (HP:0006488) | 1.68021233 |
141 | Bowed forearm bones (HP:0003956) | 1.68021233 |
142 | Sparse lateral eyebrow (HP:0005338) | 1.67902920 |
143 | Premature rupture of membranes (HP:0001788) | 1.66940520 |
144 | Difficulty climbing stairs (HP:0003551) | 1.66194744 |
145 | Stridor (HP:0010307) | 1.65900180 |
146 | Increased IgE level (HP:0003212) | 1.65836319 |
147 | Distal upper limb amyotrophy (HP:0007149) | 1.65630392 |
148 | Upper limb amyotrophy (HP:0009129) | 1.65630392 |
149 | Gastrointestinal dysmotility (HP:0002579) | 1.64991126 |
150 | Slender build (HP:0001533) | 1.63796116 |
151 | Gastrointestinal stroma tumor (HP:0100723) | 1.63630077 |
152 | Abnormality of the radial head (HP:0003995) | 1.61191441 |
153 | Bladder diverticulum (HP:0000015) | 1.60889877 |
154 | Fatigue (HP:0012378) | 1.60760502 |
155 | Sepsis (HP:0100806) | 1.60401662 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.21516465 |
2 | EEF2K | 4.18095710 |
3 | MAP3K10 | 4.06957762 |
4 | TRIB3 | 3.58395809 |
5 | PRPF4B | 3.35017413 |
6 | PKN2 | 3.13016169 |
7 | CDK12 | 2.94365570 |
8 | SMG1 | 2.89310945 |
9 | ERN1 | 2.59226840 |
10 | STK10 | 2.54303546 |
11 | ZAP70 | 2.39951916 |
12 | GRK6 | 2.26852404 |
13 | TXK | 2.07795093 |
14 | JAK3 | 2.07604909 |
15 | RIPK4 | 1.99498081 |
16 | TTN | 1.95594237 |
17 | LRRK2 | 1.89838233 |
18 | ITK | 1.79159507 |
19 | MAP3K13 | 1.76735277 |
20 | KDR | 1.71680683 |
21 | TGFBR2 | 1.67161908 |
22 | FGFR4 | 1.56963542 |
23 | SIK2 | 1.50503844 |
24 | TIE1 | 1.50496363 |
25 | FGFR3 | 1.46500792 |
26 | TGFBR1 | 1.39072196 |
27 | CDC42BPA | 1.36461678 |
28 | IRAK4 | 1.29896481 |
29 | PTK6 | 1.29277525 |
30 | BTK | 1.26551551 |
31 | MAP3K3 | 1.26451784 |
32 | MAP2K3 | 1.25390591 |
33 | MAP3K6 | 1.24443104 |
34 | CSF1R | 1.21792276 |
35 | SIK1 | 1.16581452 |
36 | HCK | 1.15262517 |
37 | TYK2 | 1.15163423 |
38 | CSK | 1.14675847 |
39 | RPS6KA4 | 1.14596493 |
40 | SYK | 1.14114427 |
41 | NEK2 | 1.12929609 |
42 | RPS6KB2 | 1.11614671 |
43 | IRAK3 | 1.11577190 |
44 | LCK | 1.10251721 |
45 | EPHB1 | 1.10090380 |
46 | MAP3K14 | 1.06926240 |
47 | NLK | 1.04415269 |
48 | CLK1 | 1.03841029 |
49 | PDGFRB | 1.02954532 |
50 | KSR2 | 1.02746742 |
51 | PRKCH | 1.02280787 |
52 | CDK4 | 1.01936917 |
53 | PDGFRA | 1.01457307 |
54 | MAP3K1 | 0.98826328 |
55 | DMPK | 0.97708729 |
56 | SIK3 | 0.96313763 |
57 | TAOK2 | 0.95804441 |
58 | * MARK2 | 0.89845544 |
59 | ALK | 0.89582148 |
60 | HIPK2 | 0.86217687 |
61 | RPS6KL1 | 0.85911736 |
62 | RPS6KA2 | 0.83891233 |
63 | JAK1 | 0.82447926 |
64 | KIT | 0.80950091 |
65 | NME2 | 0.80943492 |
66 | MAPK7 | 0.79368570 |
67 | PTK2 | 0.77301891 |
68 | TYRO3 | 0.76288599 |
69 | PAK2 | 0.76189205 |
70 | MTOR | 0.76003615 |
71 | IKBKE | 0.75827959 |
72 | RIPK1 | 0.74751764 |
73 | TEC | 0.73812494 |
74 | PASK | 0.73180098 |
75 | ILK | 0.73012104 |
76 | PAK4 | 0.72143857 |
77 | PIM1 | 0.72128147 |
78 | PRKD2 | 0.71676864 |
79 | TAOK1 | 0.71434949 |
80 | FGFR2 | 0.70569682 |
81 | PDPK1 | 0.69798498 |
82 | TNK2 | 0.69360185 |
83 | EPHA2 | 0.68472330 |
84 | FLT3 | 0.67424617 |
85 | CHUK | 0.64636069 |
86 | CDC7 | 0.63032003 |
87 | TBK1 | 0.61679914 |
88 | MARK3 | 0.61647892 |
89 | MAPK12 | 0.61609486 |
90 | BLK | 0.61473265 |
91 | STK38 | 0.60247956 |
92 | FES | 0.59715514 |
93 | BRD4 | 0.57781612 |
94 | STK4 | 0.56047632 |
95 | TESK1 | 0.54030302 |
96 | MAP3K8 | 0.53278782 |
97 | ICK | 0.53078517 |
98 | MAP2K2 | 0.52800124 |
99 | TRPM7 | 0.52738669 |
100 | PRKCQ | 0.52275751 |
101 | NTRK1 | 0.51211928 |
102 | CDK7 | 0.50687952 |
103 | JAK2 | 0.50098186 |
104 | MST1R | 0.49742329 |
105 | PDK1 | 0.48631714 |
106 | TESK2 | 0.48088582 |
107 | CDK6 | 0.47911355 |
108 | PRKD3 | 0.47708536 |
109 | MAPKAPK2 | 0.47292330 |
110 | PTK2B | 0.45569723 |
111 | IRAK2 | 0.44935198 |
112 | IKBKB | 0.43536313 |
113 | CAMK1G | 0.43229097 |
114 | FGFR1 | 0.43064416 |
115 | CHEK1 | 0.42711691 |
116 | PIM2 | 0.41542854 |
117 | CDK9 | 0.41201206 |
118 | MELK | 0.40730012 |
119 | FGR | 0.39653209 |
120 | BMX | 0.39050422 |
121 | CAMKK1 | 0.38424180 |
122 | CAMK4 | 0.38262062 |
123 | INSR | 0.37585632 |
124 | RPS6KA6 | 0.37247225 |
125 | * MAP3K7 | 0.36461407 |
126 | RET | 0.36115740 |
127 | WNK1 | 0.35498400 |
128 | MAP3K11 | 0.35347357 |
129 | LYN | 0.34599104 |
130 | PRKG2 | 0.32816744 |
131 | MAPK11 | 0.32287398 |
132 | RPS6KC1 | 0.31895759 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.86065499 |
2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.66212143 |
3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.12141536 |
4 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.98358651 |
5 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.92525811 |
6 | Other glycan degradation_Homo sapiens_hsa00511 | 1.90296762 |
7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.83384564 |
8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.80646346 |
9 | Measles_Homo sapiens_hsa05162 | 1.75935491 |
10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.74445142 |
11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.72386385 |
12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.68043172 |
13 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.58917438 |
14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.58687085 |
15 | Ribosome_Homo sapiens_hsa03010 | 1.55375114 |
16 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.50851339 |
17 | HTLV-I infection_Homo sapiens_hsa05166 | 1.50390042 |
18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.48757816 |
19 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.47309687 |
20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.47089753 |
21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.46694365 |
22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.43024287 |
23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38003914 |
24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.36653890 |
25 | Platelet activation_Homo sapiens_hsa04611 | 1.35476464 |
26 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.34143049 |
27 | DNA replication_Homo sapiens_hsa03030 | 1.32270107 |
28 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.31831490 |
29 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.31525611 |
30 | Colorectal cancer_Homo sapiens_hsa05210 | 1.30718996 |
31 | Leishmaniasis_Homo sapiens_hsa05140 | 1.30460641 |
32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.28017766 |
33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.24251812 |
34 | Hepatitis B_Homo sapiens_hsa05161 | 1.23217270 |
35 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.23125417 |
36 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.20483846 |
37 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.19765727 |
38 | Spliceosome_Homo sapiens_hsa03040 | 1.18910645 |
39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.16932816 |
40 | Focal adhesion_Homo sapiens_hsa04510 | 1.16615323 |
41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.16494792 |
42 | Thyroid cancer_Homo sapiens_hsa05216 | 1.13185430 |
43 | Shigellosis_Homo sapiens_hsa05131 | 1.13082140 |
44 | Base excision repair_Homo sapiens_hsa03410 | 1.12355445 |
45 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.11548584 |
46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.09200139 |
47 | Endometrial cancer_Homo sapiens_hsa05213 | 1.03964527 |
48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.03135484 |
49 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.00472667 |
50 | Tuberculosis_Homo sapiens_hsa05152 | 0.99977254 |
51 | Apoptosis_Homo sapiens_hsa04210 | 0.95939063 |
52 | Cell cycle_Homo sapiens_hsa04110 | 0.95860760 |
53 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95839093 |
54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.95271232 |
55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94580425 |
56 | Lysine degradation_Homo sapiens_hsa00310 | 0.93055618 |
57 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.92738504 |
58 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.92468080 |
59 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.91913016 |
60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.91348053 |
61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.90913909 |
62 | Adherens junction_Homo sapiens_hsa04520 | 0.89124156 |
63 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88905981 |
64 | Pathways in cancer_Homo sapiens_hsa05200 | 0.88230771 |
65 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.88227855 |
66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86307770 |
67 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.85702225 |
68 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.84357445 |
69 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84019016 |
70 | Prostate cancer_Homo sapiens_hsa05215 | 0.83881575 |
71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.83587230 |
72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.82788810 |
73 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.80038274 |
74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79045557 |
75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78687389 |
76 | Mismatch repair_Homo sapiens_hsa03430 | 0.77244850 |
77 | Influenza A_Homo sapiens_hsa05164 | 0.76829256 |
78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.76749759 |
79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76680647 |
80 | RNA transport_Homo sapiens_hsa03013 | 0.75919977 |
81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75698952 |
82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75601930 |
83 | Prion diseases_Homo sapiens_hsa05020 | 0.74153368 |
84 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.73270330 |
85 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.73174884 |
86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72431003 |
87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71998432 |
88 | Glioma_Homo sapiens_hsa05214 | 0.71260801 |
89 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70057301 |
90 | Pertussis_Homo sapiens_hsa05133 | 0.69237192 |
91 | Allograft rejection_Homo sapiens_hsa05330 | 0.69143508 |
92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.69004357 |
93 | Insulin resistance_Homo sapiens_hsa04931 | 0.68999386 |
94 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.66840462 |
95 | Bladder cancer_Homo sapiens_hsa05219 | 0.65800886 |
96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64613830 |
97 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64418969 |
98 | Malaria_Homo sapiens_hsa05144 | 0.64307314 |
99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63325294 |
100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62640237 |
101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61973984 |
102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61763666 |
103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59315954 |
104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58679743 |
105 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58579919 |
106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56615485 |
107 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.56585027 |
108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56451204 |
109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.56123562 |
110 | Endocytosis_Homo sapiens_hsa04144 | 0.55132499 |
111 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.54924960 |
112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54791329 |
113 | Hepatitis C_Homo sapiens_hsa05160 | 0.54245360 |
114 | Amoebiasis_Homo sapiens_hsa05146 | 0.53402639 |
115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52230713 |
116 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.51675359 |
117 | Salmonella infection_Homo sapiens_hsa05132 | 0.51568332 |
118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51397536 |
119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50401072 |
120 | RNA degradation_Homo sapiens_hsa03018 | 0.49334129 |
121 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.48298456 |
122 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48072711 |
123 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45175331 |